Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Unloaded 5,222 Shares?
Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd. (URGN +0.75%), reported the sale of 5,222 ordinary shares for a total of approximately $143,000, as disclosed in a SEC Form 4 filing. MetricValueShares sold (direct)5,222Transaction…
Electronics, pharma and engineering goods lead India's FTA dividend as export engine shifts gears
Electronics could evolve from a rapidly growing export sector into the cornerstone of India's next manufacturing and export-led growth cycle, Yes Securities said, with Monte Carlo simulations showing a 55.2 per cent probability of generating a high…
'West Asia Crisis has impacted fertilisers and Pharma sectors', says Union Minister JP Nadda
The Union Minister for Health and Family Welfare and Chemicals & Fertilisers, Jagat Prakash Nadda, said that the ongoing West Asia crisis has affected global supply chains linked to the fertiliser and pharmaceutical sectors, but assured that the…
Eventide Asset Management LLC Reduces Holdings in BridgeBio Pharma, Inc. $BBIO
Eventide Asset Management LLC lessened its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 38.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund…
Fieldview Capital Management LLC Invests $3.74 Million in Royalty Pharma PLC $RPRX
Fieldview Capital Management LLC purchased a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased…
Eventide Asset Management LLC Raises Stake in Royalty Pharma PLC $RPRX
Eventide Asset Management LLC raised its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 41.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The…
First Turn Management LLC Has $28.11 Million Position in Ascendis Pharma A/S $ASND
First Turn Management LLC lowered its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 9.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 131,808 shares…
BridgeBio Pharma, Inc. $BBIO is Frazier Life Sciences Management L.P.'s 4th Largest Position
Frazier Life Sciences Management L.P. lessened its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 7.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange…
London startup to trial drug to prevent cancer therapy side-effect 'cytokine storm'
A London-based startup is about to trial a drug at six NHS hospitals that could stop people on cancer immunotherapy getting a life-threatening side-effect. Poolbeg Pharma said its oral drug POLB 001 could make treatment for blood cancer safer by…
OpenAI says it's 'committed to learning' as a coalition of states investigates ChatGPT's impact on young users
OpenAI said it's 'committed to learning' after a coalition of states launched an investigation into how the tech startup's products impact users. An OpenAI spokesperson said in a statement that it's taking the states' concerns 'seriously' and will…
Strawberry Fields REIT: A Growth And Dividend Idea Among Skilled-Nursing REITs (NYSE:STRW)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Japanese drug firms reportedly expand in China; Tokyo urged to heed business community's calls to stabilize ties: expert
Japanese drug company Astellas Pharma will open a research and development (R&D) center in Beijing as soon as this year, which would be the company's first R&D center in China, aiming to tap the rapidly improving drug discovery capabilities of…
Rosenblatt Raises its Price Target on The Walt Disney Company (DIS)
The Walt Disney Company (NYSE:DIS) is one of the On June 5, 2026, Rosenblatt raised the firm's price target on The Walt Disney Company (NYSE:DIS) to $126 from $121 and maintained a Buy rating on the shares. The firm said Disney's current movie…
Is Bio-Techne Corporation (TECH) A Good Stock To Buy Now?
Is TECH a good stock to buy? We came across a bullish thesis on Bio-Techne Corporation on r/ValueInvesting by Dynaheir-be. In this article, we will summarize the bulls' thesis on TECH. Bio-Techne Corporation's share was trading at $52.65 as of June…
Middle-aged adults taking GLP-1s for obesity can save $192K+ on lifetime medical costs, more if they don't have college degrees, new study finds
Over 40 million Americans have reported using GLP-1 drugs for weight loss, a behavior reshaping everything from the healthcare industry to pop culture and consumer behavior—and the drugs' use could balloon into as much as a $240 billion…
Receive a Daily briefing on Pharma Industry News
Get Started